Cargando…
Identification and Evaluation of Traditional Chinese Medicine Natural Compounds as Potential Myostatin Inhibitors: An In Silico Approach
Myostatin (MSTN), a negative regulator of muscle mass, is reported to be increased in conditions linked with muscle atrophy, sarcopenia, and other muscle-related diseases. Most pharmacologic approaches that treat muscle disorders are ineffective, emphasizing the emergence of MSTN inhibition. In this...
Autores principales: | Ali, Shahid, Ahmad, Khurshid, Shaikh, Sibhghatulla, Lim, Jeong Ho, Chun, Hee Jin, Ahmad, Syed Sayeed, Lee, Eun Ju, Choi, Inho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268423/ https://www.ncbi.nlm.nih.gov/pubmed/35807547 http://dx.doi.org/10.3390/molecules27134303 |
Ejemplares similares
-
Computational Identification of Dithymoquinone as a Potential Inhibitor of Myostatin and Regulator of Muscle Mass
por: Ahmad, Syed Sayeed, et al.
Publicado: (2021) -
MIF1 and MIF2 Myostatin Peptide Inhibitors as Potent Muscle Mass Regulators
por: Lee, Eun Ju, et al.
Publicado: (2022) -
Biocomputational Screening of Natural Compounds against Acetylcholinesterase
por: Ahmad, Syed Sayeed, et al.
Publicado: (2021) -
Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies
por: Baig, Mohammad Hassan, et al.
Publicado: (2022) -
A Comprehensive Review and Perspective on Natural Sources as Dipeptidyl Peptidase-4 Inhibitors for Management of Diabetes
por: Shaikh, Sibhghatulla, et al.
Publicado: (2021)